Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4B |
| 2 |
TC Energy
TRP
|
+$1.99B |
| 3 |
Amazon
AMZN
|
+$1.97B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.83B |
| 5 |
NVIDIA
NVDA
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.57B |
| 2 |
Scotiabank
BNS
|
+$1.51B |
| 3 |
Enbridge
ENB
|
+$1.47B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.02B |
| 5 |
Medtronic
MDT
|
+$871M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 9.2% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Communication Services | 6.4% |
| 5 | Healthcare | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
United Therapeutics
UTHR
$22B
| $34.2M | ﹤0.01% |
81,536
-66,662
| -45% | -$22.4M |
|
1752
Novanta
NOVT
$5.45B
| $34.1M | ﹤0.01% |
340,025
+11,377
| +3% | +$1.35M |
|
1753
Arcutis Biotherapeutics
ARQT
$3.39B
| $34M | ﹤0.01% |
1,804,988
-85,258
| -5% | -$1.34M |
|
1754
The RealReal
REAL
$1.52B
| $34M | ﹤0.01% |
3,200,270
-94,978
| -3% | -$703K |
|
1755
IES Holdings
IESC
$15.6B
| $34M | ﹤0.01% |
85,537
+6,983
| +9% | +$2.4M |
|
1756
PUT
Zoom
ZM
$29.5B
| $34M | ﹤0.01% |
412,000
+282,800
| +219% | +$22.1M |
|
1757
CALL
Ferrari
RACE
$71.5B
| $34M | ﹤0.01% |
+70,000
| New | +$33.5M |
|
|
SFBS
1758
ServisFirst Bancshares
SFBS
$4.94B
| $34M | ﹤0.01% |
421,587
+104,118
| +33% | +$8.63M |
|
1759
Patrick Industries
PATK
$2.9B
| $33.9M | ﹤0.01% |
328,069
+68,767
| +27% | +$7.23M |
|
|
JBTM
1760
JBT Marel
JBTM
$6.35B
| $33.9M | ﹤0.01% |
241,528
+156,492
| +184% | +$21.4M |
|
1761
VanEck High Yield Muni ETF
HYD
$4.44B
| $33.9M | ﹤0.01% |
666,253
-190,380
| -22% | -$9.47M |
|
1762
CALL
Cigna
CI
$71.5B
| $33.8M | ﹤0.01% |
117,200
+54,300
| +86% | +$16.1M |
|
|
DCH
1763
Dauch Corp
DCH
$1.42B
| $33.8M | ﹤0.01% |
5,620,991
+3,198,324
| +132% | +$17.1M |
|
1764
Pacira BioSciences
PCRX
$991M
| $33.8M | ﹤0.01% |
1,309,988
+1,087
| +0.1% | +$26.7K |
|
1765
Hamilton Lane
HLNE
$5.56B
| $33.7M | ﹤0.01% |
250,327
-66,069
| -21% | -$9.97M |
|
1766
CALL
CRH
CRH
$66.5B
| $33.6M | ﹤0.01% |
+280,300
| New | +$29.6M |
|
1767
Kaspi.kz JSC
KSPI
$17.5B
| $33.6M | ﹤0.01% |
410,878
-13,702
| -3% | -$1.2M |
|
1768
IDEAYA Biosciences
IDYA
$3.47B
| $33.6M | ﹤0.01% |
1,233,113
+4,929
| +0.4% | +$119K |
|
|
NTSK
1769
Netskope Inc
NTSK
$5.69B
| $33.5M | ﹤0.01% |
+1,474,002
| New | +$35.1M |
|
1770
United Microelectronic
UMC
$48.4B
| $33.4M | ﹤0.01% |
4,411,850
-1,173,732
| -21% | -$8.33M |
|
1771
ICU Medical
ICUI
$4.16B
| $33.4M | ﹤0.01% |
278,714
+78,094
| +39% | +$9.89M |
|
1772
Iridium Communications
IRDM
$5.13B
| $33.4M | ﹤0.01% |
1,914,267
+1,789,196
| +1,431% | +$44.2M |
|
1773
Encore Capital Group
ECPG
$1.99B
| $33.3M | ﹤0.01% |
798,914
+227,836
| +40% | +$9.36M |
|
1774
iShares Global REIT ETF
REET
$5.13B
| $33.3M | ﹤0.01% |
1,302,746
+99,229
| +8% | +$2.49M |
|
1775
CALL
Carnival Corporation Ltd
CCL
$40.6B
| $33.2M | ﹤0.01% |
1,149,100
-7,500
| -0.6% | -$226K |
|
Similar funds
Goldman Sachs's Q3 2025 Portfolio in Review
As of Q3 2025, Goldman Sachs held 6,765 positions worth $817B, up 11% from $736B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q3 2025 filing shows 707 new, 2,950 increased, 2,106 reduced and 470 closed positions. Its largest new stake was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M. The largest sale was iShares Russell 2000 ETF, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q3 2025 buy was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M.
- Goldman Sachs added most to Microsoft in Q3 2025, an estimated $4B increase.
- Goldman Sachs's biggest Q3 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $1.57B.
- Goldman Sachs fully exited Ansys in Q3 2025, selling an estimated $564M.
- Goldman Sachs's ten largest holdings make up 22% of its $817B portfolio in Q3 2025.
- Goldman Sachs opened 707 new positions and closed 470 in Q3 2025.
- Goldman Sachs's portfolio value rose 11% quarter-over-quarter to $817B.
Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.